Our Mission and Goal
Our mission is to regenerate tissue by facilitating innate healing – the body’s inborn ability to restore and protect itself – to cure underlying disease, rather than simply manage symptoms or slow disease progression. Our initial goal is to do this for patients with ischemic disorders, beginning with diabetic ulcers.
The company has a management team with exceptional experience.
Thomas A. Moore, Chairman and CEO, was formerly CEO of two publicly held biotech companies and, before that, President of Healthcare, Procter & Gamble.
Boris Leschinsky, PhD., Founder and CTO. Formerly, VP Technology, Datascope.
Abe Abramovich, Co-founder & Chief Engineering Officer, responsible for product development. Formerly, founder & Principal Consultant, ProMed Technologies; Director of Advanced Product Development, Datascope.
Kirk Garratt, MD, Chief Medical Officer. Also serves as Associate Director, Christiana Care Health System. Former Clinical Director of Interventional Cardiology, Lenox Hill Hospital, NYC.
Todd Greenwood, PhD, MPH, Director of Marketing, More than 20 years’ experience in healthcare marketing.
Eleanor Haas, Director of Investor Relations and Communications. More than 20 years experience.
The company has medical thought leaders as advisors.
Karin Przyklenk, PhD., Director, Cardiovascular Research Institute; Professor, Physiology & Emergency Medicine, Wayne State University.
William W. O’Neill, MD, Medical Director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit.
Charles V. Pollack, MD, Chair of Emergency Dept., U of Pennsylvania Hospital, Philadelphia.
Douglas M. Hansell, MD, Chief Physician Executive, Cheetah Medical; Former Chief Medical Officer, GE Healthcare.
David G. Armstrong, DPM, MD, PhD, Professor of Surgery and Director. Southwestern Academic Limb Salvage Alliance (SALSA) at Keck School of Medicine, USC
Board of Directors
Thomas A. Moore, Chairman and CEO
Boris Leschinsky, Founder and CTO
Abe Abramovich, SVP and Chief Engineering Officer
Kirk N. Garratt, MD, Chief Medical Officer
Mark Abramovich, SVP of Strategy and Market Planning, Charles Jones